UroChat

Why Low-Dose-Rate Brachytherapy Deserves a Second Look

Why low-dose-rate brachytherapy deserves renewed consideration for localized prostate cancer.

EMPIRE-2 Trial: Optimizing Molecular Imaging for Biochemical Recurrence After Prostatectomy

How EMPIRE-2 reshapes PET imaging for biochemical recurrence.

The Reality of Real World Data

Why clinicians should look beyond the label "real-world data" when evaluating clinical evidence.

Fireside Chat with Vic Lombardi

A patient’s journey through diagnosis, recurrence, and resilience.